全文获取类型
收费全文 | 23528篇 |
免费 | 2343篇 |
国内免费 | 7篇 |
专业分类
25878篇 |
出版年
2022年 | 131篇 |
2021年 | 269篇 |
2020年 | 175篇 |
2019年 | 196篇 |
2018年 | 279篇 |
2017年 | 280篇 |
2016年 | 485篇 |
2015年 | 829篇 |
2014年 | 922篇 |
2013年 | 1133篇 |
2012年 | 1502篇 |
2011年 | 1575篇 |
2010年 | 1039篇 |
2009年 | 908篇 |
2008年 | 1285篇 |
2007年 | 1419篇 |
2006年 | 1205篇 |
2005年 | 1236篇 |
2004年 | 1242篇 |
2003年 | 1158篇 |
2002年 | 1111篇 |
2001年 | 333篇 |
2000年 | 295篇 |
1999年 | 362篇 |
1998年 | 379篇 |
1997年 | 285篇 |
1996年 | 268篇 |
1995年 | 252篇 |
1994年 | 269篇 |
1993年 | 249篇 |
1992年 | 297篇 |
1991年 | 225篇 |
1990年 | 226篇 |
1989年 | 218篇 |
1988年 | 216篇 |
1987年 | 217篇 |
1986年 | 188篇 |
1985年 | 229篇 |
1984年 | 270篇 |
1983年 | 198篇 |
1982年 | 244篇 |
1981年 | 227篇 |
1980年 | 200篇 |
1979年 | 147篇 |
1978年 | 131篇 |
1977年 | 133篇 |
1976年 | 142篇 |
1975年 | 107篇 |
1974年 | 131篇 |
1973年 | 105篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
Based on its proven anabolic effects on bone in osteoporosis patients, recombinant parathyroid hormone (PTH1-34) has been evaluated as a potential therapy for skeletal repair. In animals, the effect of PTH1-34 has been investigated in various skeletal repair models such as fractures, allografting, spinal arthrodesis and distraction
osteogenesis. These studies have demonstrated that intermittent PTH1-34 treatment enhances and accelerates the skeletal repair process via a number of mechanisms, which include effects on mesenchymal
stem cells, angiogenesis, chondrogenesis, bone formation and resorption. Furthermore, PTH1-34 has been shown to enhance bone repair in challenged animal models of aging, inflammatory arthritis and glucocorticoid-induced
bone loss. This pre-clinical success has led to off-label clinical use and a number of case reports documenting PTH1-34 treatment of delayed-unions and non-unions have been published. Although a recently completed phase 2 clinical trial of PTH1-34 treatment of patients with radius fracture has failed to achieve its primary outcome, largely because of effective healing
in the placebo group, several secondary outcomes are statistically significant, highlighting important issues concerning the
appropriate patient population for PTH1-34 therapy in skeletal repair. Here, we review our current knowledge of the effects of PTH1-34 therapy for bone healing, enumerate several critical unresolved issues (e.g., appropriate dosing regimen and indications)
and discuss the long-term potential of this drug as an adjuvant for endogenous tissue engineering. 相似文献
3.
Keratinocyte growth-promoting activity from human placenta 总被引:4,自引:0,他引:4
Extracts of term human placenta were tested for enhancement of proliferative growth of primary cultures of human keratinocytes. Saline extracts or supernatants from homogenates were dialyzed extensively, lyophilized, and tested in subcultures of keratinocytes in MCDB 153 medium with 0.1 mM Ca++ containing only defined supplements (insulin, hydrocortisone, transferrin, ethanolamine, phosphoethanolamine). Cells plated in the absence of EGF at moderately high densities (1000-3000 cells per cm2) formed colonies and grew in the presence of placental extract at 25-500 micrograms/ml. Extracts of cord serum or maternal serum were inactive, suggesting that the activity is derived from placental tissue. The activity is not EGF, since the activity in the placental extract, unlike EGF, did not promote growth at low cell density, was synergistic with EGF under some conditions, and did not produce changes in colonial morphology which occurred in the presence of EGF. Unlike keratinocyte growth-promoting activity in bovine hypothalamic extract, the activity is non-dialyzable and is destroyed at 100 degrees C. Placental extract could not replace any of the defined components of the medium and is therefore distinct from them. The presence of activity in the placenta with distinctive properties suggests that this is a previously undescribed material with growth-promoting properties for epithelium. 相似文献
4.
5.
6.
William Russell 《BMJ (Clinical research ed.)》1985,290(6485):1914
7.
Bruce R. Dorrbecker Susan H. Mercik Paul A. Kramer 《Journal of chromatography. B, Analytical technologies in the biomedical and life sciences》1984,336(1)
A high-performance liquid chromatographic procedure is reported for reproducibly and sensitively quantitating caffeine and its N-demethylated metabolite paraxanthine in micro-samples. A 5-μm reversed-phase radial compression column and 214-nm fixed wavelength ultraviolet detector were used to attain a sensitivity sufficient to quantitate these compounds at concentratios as low as 80 ng/ml using only 25 μl of sample. The assay is applicable to microliter samples of whole blood, serum, plasma, saliva, amniotic, cerebro-spinal and gastric fluids such as might be obtained in studies involving small animals or neonates. The utility of the assay is illustrated with caffeine and paraxanthine levels measured in several maternal and fetal fluids following constant-rate intravenous infusion of caffeine into a rabbit throughout pregnancy. 相似文献
8.
Rebecca R. Sharitz Susan A. Wineriter Michael H. Smith Edwin H. Liu 《American journal of botany》1980,67(9):1297-1303
Biochemical phenotsypes of four taxa of Typha from the eastern United States were determined by starch gel electrophoresis. The isozyme banding patterns of T. latifolia, T. angustifolia and T. domingensis are distinct and allow unambiguous species identification when morphological characters are inadequate or unsuitable. The fourth form, T. glauca, is not an F1 hybrid, but it does appear to be intermediate between T. latifolia and T. angustifolia. The status of T. glauca and evolutionary relationships among the four forms may now be clarified by additional sampling because of the distinct and relatively invariant isozyme banding patterns which are described. 相似文献
9.
S20Y murine neuroblastoma cells appear to express a protein component(s) able to adhere specifically to the oligosaccharide portion of GM1 (oligo-GM1). To identify proteins with which the oligo-GM1 becomes closely associated, a radiolabeled (125I), photoactivatable derivative of oligo-GM1 was prepared. This was accomplished by reductive amination of the glucosyl moiety of oligo-GM1 to 1-deoxy-1-aminoglucitol, followed by reaction of the amine with sulfosuccinimidyl 2-(p-azidosalicylamido)ethyl-1,3'-dithiopropionate (SASD). Crosslinking studies using the photoactivatable probe indicated that it came in close proximity to a protein with an apparent molecular mass of approximately 71 kDa. In competition experiments, as little as a 10-fold molar excess of oligo-GM1 resulted in a selective reduction in labeling of this protein; preincubation with a 200-fold molar excess of siayllactose was necessary to observe the same change in the labeling pattern, lending additional support to the hypothesis that the approximately 71-kDa protein specifically associates with oligo-GM1. Cell surface location of the oligo-GM1 binding protein was confirmed using subcellular fractionation and morphological analyses. 相似文献
10.